Rat pancreatic and intestinal sections with an antiserum for human GLP-1 (737) (Phoenix Pharmaceuticals, Mountain View, California, USA) at a concentration of 1/500
This was done multiple times, excluding a different study in each instance
Researchers reviewed up to three years of health records after participants began taking either a GLP-1 receptor agonist, most commonly semaglutide, liraglutide, or dulaglutide, or an SGLT2 inhibitor, another type of diabetes medication
Ferrannini E, Mark M, Mayoux E
Within GLP-1 receptor research, it remains a benchmark compound for comparator studies in laboratories worldwide
Through its , prospective franchisees gain access to tools, insights and guidance designed to simplify the franchise discovery process